Skip to main content
. Author manuscript; available in PMC: 2019 Feb 3.
Published in final edited form as: Semin Thorac Cardiovasc Surg. 2015 Apr 8;27(1):36–48. doi: 10.1053/j.semtcvs.2015.04.002

Figure 3.

Figure 3.

The components of precision therapy. Abnormalities in the genome, epigenome, and transcriptome can be targeted using several interventions including small molecule inhibitors, monoclonal antibodies, epigenetic strategies, and small interfering RNAs. Immune dysregulation can be targeted using vaccines against tumor-specific antigens, immune checkpoint inhibitors to block cell surface inhibitory molecules, and adoptive cell transfer technologies.